Showing results (51-60 of 94) with videos related to
Sort By:
Pageof 10
American Journal of Biological Anthropology|January 25, 2024
Variation, sexual dimorphism, and enlargement of the frontal sinus with age in adult South AfricansVictoria A Greening, Emily Hernandez, Carrie S Mongle, et al.Diabetes Care|February 28, 2018
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical TrialLiana K Billings, Ankur Doshi, Didier Gouet, et al.Journal of Diabetes Science and Technology|February 29, 2020
The Benefit of Insulin Degludec/Liraglutide (IDegLira) Compared With Basal-Bolus Insulin Therapy is Consistent Across Participant Subgroups With Type 2 Diabetes in the DUAL VII Randomized TrialLiana K Billings, Bue F Ross Agner, Yuksel Altuntas, et al.Diabetes, Obesity & Metabolism|February 15, 2019
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetesAthena Philis-Tsimikas, Liana K Billings, Robert Busch, et al.Endocrinology, Diabetes & Metabolism|October 8, 2022
Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohortLiana K Billings, Zhuqing Shi, W Kyle Resurreccion, et al.Journal of Chemical Neuroanatomy|July 28, 2020
Nuclear organization and morphology of catecholaminergic neurons and certain pallial terminal networks in the brain of the Nile crocodile, Crocodylus niloticusBrendon K Billings, Adhil Bhagwandin, Nina Patzke, et al.Journal of Diabetes Science and Technology|January 30, 2023
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 DiabetesAthena Philis-Tsimikas, Vanita R Aroda, Christophe De Block, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 11, 2023
Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO StudyRonald M Goldenberg, Vanita R Aroda, Liana K Billings, et al.Diabetes, Obesity & Metabolism|August 7, 2019
IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapyEden Miller, Ankur Doshi, Randi Grøn, et al.The American Journal of Clinical Nutrition|February 1, 2013
Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjectsSoo Lim, Min Joo Kim, Sung Hee Choi, et al.Pageof 10